EpimAb Biotherapeutics | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Conferences Trial results

11 November 2024

ASH 2024 preview – multiple myeloma in focus

AbbVie looks to justify its faith in TeneoOne, and Bristol its phase 3 move with BMS-986393.

Subscribe to EpimAb Biotherapeutics